Quantcast
  • E-mail
  • Print
  • Comment
  • Font Size
  • Digg
  • del.icio.us
  • Discuss article

ThalesNano and Sanofi-Aventis Collaborate on Continuous Process Technologies

Posted on: Friday, 23 May 2008, 12:00 CDT

ThalesNano and Sanofi-Aventis have signed a R&D collaboration agreement focusing on continuous process chemistry technologies.

The collaboration will focus on the development and implementation of continuous process technologies from research to full-scale production. The purpose of the project is to study the utilization and application of ThalesNano's integrated continuous process chemistry technologies within the Sanofi-Aventis drug R&D process from discovery to API production.

Ferenc Darvas, president and chairman of ThalesNano, said: "The benefits of continuous process chemistry over conventional batch chemistry includes the rapid synthesis of organic compounds, in particular under until now unrealizable hazardous reaction conditions."


Source: Datamonitor

More News in this Category


Related Articles



Rating: 3.0 / 5 (6 votes)
Rate this article:
1/52/53/54/55/5

User Comments (0)

Comment on this article

Your Name
Text from the image
Comment
max 1200 chars
* All fields are required

redOrbit Friends